Company Overview

Update
Founded:
2002
Headquarters:
Leiden
IPO:
Went Public on Jul 1, 2013
Stock:
NASDAQ:RNA
Categories:
Biotechnology

Prosensa provides RNA-based therapeutics for the treatment of genetic disorders, infections and cancers.

Description

Update

Prosensa is a biotech company dedicated to the commercialization of products for the healthcare market based on RNA-based therapeutics.

During the development of this technology, it became clear that many opportunities exist for the development of these products into novel commercially attractive products. These products are mainly in the field of genetic disorders, anti-infectives and oncology.

Prosensa will focus to maximize the commercial development of the current program, and take advantage of the large novel market opportunities supported by a strong IP position. Prosensa will initially operate mainly as a focussed company, outsourcing most of its activities to specialized organizations.

Current Team (17)

Update

Board Members and Advisors (3)

Update

Funding Rounds (2) - $55.10M

Update

Investors (7)

Update

Offices/Locations (2)

Update
  • Office

    Wassenaarseweg 72

    2333 AL Leiden

    ,

    The Netherlands

  • Office

    Leiden,

    NLD

Images (1)

Update
  • De2363156125a234f9159cc699082330